PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation.

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Olaizola P, Banales JM.

Journal title: Cell Mol Gastroenterol Hepatol

Journal publisher: Elsevier Inc.

Published year: 2023

DOI identifier: 10.1016/j.jcmgh.2023.02.015

ISSN: 2352-345X